ACTINIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 00507W906. A total of 3 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $285,936 | +7.6% | 48,300 | +34.9% | 0.00% | 0.0% |
| Q2 2023 | $265,636 | -35.1% | 35,800 | -17.3% | 0.00% | 0.0% |
| Q1 2023 | $409,185 | -62.4% | 43,300 | -57.6% | 0.00% | -66.7% |
| Q4 2022 | $1,088,430 | +58.7% | 102,200 | +10.0% | 0.00% | +200.0% |
| Q3 2022 | $686,000 | +54.9% | 92,900 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $443,000 | -39.4% | 92,100 | -35.6% | 0.00% | 0.0% |
| Q1 2022 | $731,000 | +62.8% | 143,100 | +91.6% | 0.00% | – |
| Q4 2021 | $449,000 | -2.8% | 74,700 | +43.1% | 0.00% | – |
| Q3 2021 | $462,000 | -13.5% | 52,200 | -22.7% | 0.00% | -100.0% |
| Q2 2021 | $534,000 | +14.6% | 67,500 | +10.3% | 0.00% | 0.0% |
| Q1 2021 | $466,000 | +125.1% | 61,200 | +130.1% | 0.00% | – |
| Q4 2020 | $207,000 | -83.1% | 26,600 | -78.9% | 0.00% | -100.0% |
| Q3 2020 | $1,224,000 | – | 126,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 92,900 | $686,000 | 0.00% |
| SIMPLEX TRADING, LLC | 100,000 | $738,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |